Clinical Trials Browser

Phase 1/2 × gossypol acetic acid × Lymphoid × Clear all

NCT05338931 2022-05-26

Safety, Tolerability, and Efficacy of AT101 in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

Phase 1/2 Recruiting

Lymphoma, B-Cell

NCT01003769 2020-06-16

Lenalidomide and AT-101 in Treating Patients With Relapsed B-Cell Chronic Lymphocytic Leukemia

Phase 1/2 Terminated

5 enrolled 7 charts

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell